Author:
Fidler Isaiah J.,Ellis Lee M.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference18 articles.
1. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 1, 571–573 (1889).
2. Fidler, I.J. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 50, 6130–6138 (1990).
3. Fidler, I.J. & Kripke, M.L. Metastasis results from pre-existing variant cells within a malignant tumor. Science 197, 893–895 (1977).
4. Fidler, I.J. Modulation of the organ microenvironment for the treatment of cancer metastasis. J. Natl. Cancer Inst. 84, 1588–1592 (1995).
5. Browder, T. et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 60, 1878–1886 (2000).
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metronomic Chemotherapy After Palliative Radiotherapy in Rare Soft Tissue Sarcomas: An Insight into Radiation Therapy and the Immune Response;Indian Journal of Surgical Oncology;2024-05-25
2. A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial;ESMO Open;2024-05
3. Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor;Journal of Chemistry;2024-03-01
4. Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression;Pathology - Research and Practice;2023-12
5. Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers;Computational Biology and Chemistry;2023-12